Edwards Lifesciences Corp. Bottom Line Advances 23% In Q3

(RTTNews) - Edwards Lifesciences Corp. (EW) announced earnings for its third quarter that gained ground compared to the same period last year.

The company said its bottom line came in at $181.8 million, or $0.84 per share. This was up from $148.3 million, or $0.68 per share, in last year's third quarter.

Analysts had expected the company to earn $0.86 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 11.1% to $821.5 million. This was up from $739.4 million last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q3): $181.8 Mln. vs. $148.3 Mln. last year. -Earnings Growth (Y-o-Y): 22.6% -EPS (Q3): $0.84 vs. $0.68 last year. -EPS Growth (Y-o-Y): 23.5% -Analysts Estimate: $0.86 -Revenue (Q3): $821.5 Mln vs. $739.4 Mln last year. -Revenue Change (Y-o-Y): 11.1%

-Guidance: Next quarter EPS guidance: $0.84 - $0.94 Next quarter revenue guidance: $855 - $895 Mln Full year EPS guidance: $3.65 - $3.85 Full year revenue guidance: $3.2 - $3.4 Bln